Impaired function of human T-lymphotropic virus type 1 (HTLV-1) specific CD8 + T cells in HTLV-1 associated neurologic disease

Blood

Volumn 112, Issue 6, 2008, Pages 2411-2420

  Sabouri, Amir H ^a   Usuku, Koichiro ^b   Hayashi, Daisuke ^a   Izumo, Shuji ^a   Ohara, Yoshiro ^c   Osame, Mitsuhiro ^a   Saito, Mineki ^c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; GRANZYME B; HLA A2 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PERFORIN; TAX PROTEIN; T LYMPHOCYTE RECEPTOR;

ADULT; ALLELE; ARTICLE; CD8+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; DEGRANULATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS CARRIER; VIRUS LOAD; CYTOTOXIC T LYMPHOCYTE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; IMMUNOPHENOTYPING; PATHOGENICITY; PATHOLOGY; VIROLOGY;

CD8-POSITIVE T-LYMPHOCYTES; HLA-A2 ANTIGEN; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOPHENOTYPING; PARAPARESIS, TROPICAL SPASTIC; PERFORIN; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 55249117798     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-140335     Document Type: Article

References (40)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77: 7415-7419.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79: 2031-2035.
3. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78:6476-6480.
4. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81:2534-2537.
5. Gessain A. Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-l in patients with tropical spastic paraparesis. Lancet. 1985;2: 407-410.
6. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986:1:1031-1032.
7. Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy. Neuropathology. 2000; 20(suppl):S65-68.
8. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997;15:15-37.
9. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586-593.
10. Jeffery KJ, Siddiqui AA, Bunce M, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 2000;165:7278-7284.
11. Jeffery KJ, Usuku K, Hall SE, et al. HLAalleles determine human T-lymphotropic virus-l (HTLV-I) proviral load and the risk of HTLV-l-associated myelopathy. Proc Natl Acad Sci U S A. 1999;96: 3848-3853.
12. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386-1392.
13. Hanon E. Stinchcombe JC, Saito M, etal. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657-664.
14. + lymphocytes directly in peripheral blood of HTLV-lassociated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol. 1998;161:482-488.
15. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005;6:873-879.
16. + lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol. 2004;173:5121-5129.
17. + lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol. 2000:102:208-215.
18. Wodarz D, Hall SE, Usuku K, et al. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci. 2001;268:1215-1221.
19. Goon PK, Biancardi A, Fast N, et al. Human Tcell lymphotropic virus (HTLV) type-1-specific GD8+ Tcells: frequency and immunodominance hierarchy. J Infect Dis. 2004;189:2294-2298.
20. Appay V, Dunbar PR, Callan M, etal. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-385.
21. Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol. 2005;174: 1037-1045.
22. + Tcells. Blood. 2006; 107:4781-4789.
23. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. New York, NY: Raven Press; 1990.
24. Rubio V, StugeTB, Singh N. etal. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med. 2003;9:1377-1382.
25. Burkett MW, Shafer-Weaver KA, Strobl S, Baseler M, Malyguine A. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J Immunother (1997). 2005;28:396-402.
26. Gillespie GM, Wills MR, Appay V, et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol. 2000;74:8140-8150.
27. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med. 1998;187:1395-1402.
28. Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type l-infected individuals: its implications in the immunodeficient state. Blood. 2001;97:3177-3183.
29. Asquith B, Zhang Y, Mosley AJ, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A. 2007;104:8035-8040.
30. Choremi-Papadopoulou H, Panagiotou N, Samouilidou E, et al. CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS. Clin Exp Immunol. 2000;119:499-506.
31. + T cells from HIV-infected subjects. Clin Exp Immunol. 1995:100: 425-433.
32. Zhang D, Shankar P, Xu Z, et al. Most antiviral CDS Tcells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood. 2003; 101:226-235.
33. Wherry EJ, Ahmed R. Memory CDS T-cell differentiation during viral infection. J Virol. 2004;78: 5535-5545.
34. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8(+) Tcells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63-75.
35. Haridas V, McCloskey TW, Pahwa R, Pahwa S. Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents. AIDS. 2003;17:2313-2322.
36. Chen G, Shankar P, Lange C, et al. CD8 Tcells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood. 2001;98:156-164.
37. + T lymphocytes. J Immunol. 2001;167:181-187.
38. Klingstrom J, Gudmundsdotter L, Zuber B, et al. Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection. AIDS. 2006;20: 125-127.
39. Bangham CR. The immune control and cell-tocell spread of human T-lymphotropic virus type 1. J Gen Virol. 2003;84:3177-3189.
40. Valitutti S, Muller S. Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med. 1996;183:1917-1921.